Retatrutide FAQ: Common Questions Answered | Retatrutide Dr
Is Retatrutide FDA Approved?
H2 section for strong_section keyword placement.
The following questions address regulatory status, availability, and prescription access.
Retatrutide Availability and Regulatory Status
H2 section for strong_section keyword placement.
Retatrutide is an investigational compound with no approved indication in the US, EU, or any other jurisdiction as of mid-2026. The TRIUMPH-1 pivotal Phase 3 trial results were reported in May 2026. An NDA submission to the FDA is anticipated in Q4 2026; regulatory approval under a standard 10-month FDA review would be projected in late 2027 to Q1 2028 [21].